Four pharma firms fined for obstructing antitrust investigation in China
MLex Summary: Four pharmaceutical companies have been fined for obstructing an antitrust investigation into the market for a raw material used in drug manufacturing, according to a penalty notice issued by...To view the full article, register now.
Already a subscriber? Click here to view full article